Hosencare Fund

Hosencare Brothers operates as a specialized private equity investment management firm, strategically deploying capital within the expansive "Big Bio, One Health" sector. The firm's approach is deeply rooted in industry insights, identifying and nurturing promising ventures across biotechnology, pharmaceuticals, and health-related enterprises. This supports companies developing innovative solutions in an evolving global health landscape.

Founded in 2017, Hosencare Brothers was established on the insight that China's burgeoning life sciences and healthcare markets required dedicated, sector-specific investment. Its inception aimed to provide strategic capital and expertise, unlocking growth opportunities in this complex domain by bridging capital with scientific and industrial innovation.

The firm’s portfolio companies span various health industry segments, including entities like Qingke Biological, benefiting from Hosencare Brothers’ focused investment. Its vision is to be a pivotal force in advancing health and biological innovations, fostering technologies and services that address critical wellness needs and contribute to a healthier global future.